title: Somatomedin C augments FSH-induced differentiation of cultured rat granulosa cells.
abstract: Growth hormone (GH) deficiency in rats is associated with decreased ovarian steroidal responsiveness to gonadotropins, possibly through a reduction in the production of the GH-dependent Somatomedin C/insulinlike growth factor I (SM C/IGF I). We have investigated the direct effects of synthetic SM C/IGF I on gonadotropin-stimulated ovarian steroidogenesis in vitro. Granulosa cells were cultured in a serum-free medium for 48 h in the presence of follicle-stimulating hormone (FSH), with or without SM C/IGF I. FSH dose-dependently increased both estrogen and progestin production. Concomitant treatment with SM C/IGF I led to a dose-dependent augmentation of progestin secretion over the full range of FSH doses tested, by a maximum of 2.3- to 2.6-fold. FSH-stimulated estrogen was enhanced by up to 2.4-fold but only at low doses of FSH. SM C/IGF I-enhanced progestin production was associated with increased pregnenolone production and 3 beta-hydroxysteroid dehydrogenase activity, whereas augmented estrogen production appeared to be due to enhanced aromatase activity. The actions of SM C/IGF I, at physiologically relevant concentrations were correlated with increased extracellular cAMP accumulation and cellular protein content but were independent of any change in cell number or viability. In contrast to SM C/IGF I, the closely related peptide multiplication-stimulating activity decreased estrogen production while increasing progestin metabolite accumulation. The present results indicate that the GH-dependent peptide SM C/IGF I may play a role in ovarian development by enhancing gonadotropin-stimulated granulosa cell steroidogenesis.
authors.forename: J B
authors.initials: JB
authors.lastname: Davoren
authors.forename: J W
authors.initials: JW
authors.lastname: Hsueh
authors.forename: C H
authors.initials: CH
authors.lastname: Li
mesh_terms: D015089:20-Hydroxysteroid Dehydrogenases / Q000378:metabolism; D004092:20-alpha-Dihydroprogesterone / Q000096:biosynthesis; D015096:3-Hydroxysteroid Dehydrogenases / Q000378:metabolism; D000818:Animals; D002454:Cell Differentiation; D002455:Cell Division; D002470:Cell Survival; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D004967:Estrogens / Q000096:biosynthesis*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000502:physiology*; D006107:Granulosa Cells / Q000166:cytology / Q000378:metabolism*; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D010455:Peptides / Q000502:physiology; D011374:Progesterone / Q000096:biosynthesis; D011372:Progestins / Q000096:biosynthesis*; D011506:Proteins / Q000378:metabolism; D051381:Rats; D013002:Somatomedins / Q000502:physiology*
chemical_list: D004967:Estrogens; D010455:Peptides; D011372:Progestins; D011506:Proteins; D013002:Somatomedins; D004092:20-alpha-Dihydroprogesterone; D011374:Progesterone; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D005640:Follicle Stimulating Hormone; D000242:Cyclic AMP; D015096:3-Hydroxysteroid Dehydrogenases; D015089:20-Hydroxysteroid Dehydrogenases